0597-0047 : Viramune 50 mg/5ml Oral Suspension


NDC: 0597-0047
Labeler: Boehringer Ingelheim Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Viramune
Dosage Form: Oral Suspension
Application #: NDA020933
Rev. Date: 


NDC Package Codes:

  • 0597-0047-24: 1 BOTTLE, PLASTIC IN 1 CARTON (0597‑0047‑24) > 240 ML IN 1 BOTTLE, PLASTIC

Active Ingredients:

  • Nevirapine

Dosage Strength:

  • 50 mg/5mL

Pharmaceutical Classes:

  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Non-Nucleoside Analog [EXT]
  • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0597-0046 Viramune 200 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals Inc.
  • 0597-0123 24 Hr Viramune 400 mg Extended Release Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0129 24 Hr Viramune 100 mg Extended Release Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 53808-0808 Viramune 200 mg Oral Tablet by State of Florida Doh Central Pharmacy
  • 54569-4561 Viramune 200 mg Oral Tablet by A-s Medication Solutions
  • 54569-6236 Viramune 400 mg Oral Tablet, Extended Release by A-s Medication Solutions
  • 54868-6370 24 Hr Viramune 400 mg Extended Release Tablet by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0597-0047 QR Code

< Prev: 0597-0046Next: 0597-0051 >

Related Discussions:

ILVITRIMl / Nevirapine
Hi after six weeks checkup my daughter tested negative, before she was using Nevirapine. Now they gave her the ilvitrim ... 3 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.